ENTITY

Ainos (AIMD US)

41
Analysis
Information Technology • United States
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its smelltech platform, powered by AI Nose and smell language model (SLM), digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Active clinical programs include HIV-related oral warts, primary Sjögren’s syndrome, and feline chronic gingivostomatitis (FCGS). Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age.
more
bullish•Ainos
•01 Oct 2026 07:40•Issuer-paid

Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform

VASRO has published an update report on Ainos, Inc. (NASDAQ: AIMD) following the company’s VELDONA licence announcement of 24 September 2026 and...

Logo
89 Views
Share
bullish•Ainos
•18 Sep 2026 08:17•Issuer-paid

Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion

VASRO has published an update report on Ainos, Inc. following the company’s announcement of 14 September 2026.Two facts arrived in the same release.

Logo
90 Views
Share
bullish•Ainos
•07 Aug 2026 16:00•Issuer-paid

Ainos, Inc.: 613 Million Records, and a Cost Base That Did Not Move — First Half 2026 Update

VASRO has published an update report on Ainos, Inc. following the company’s first-half 2026 results. The central message is not that financial...

Logo
89 Views
Share
bullish•Ainos
•06 Aug 2026 01:00•Issuer-paid

Ainos (AIMD): Building an AI Platform for Environmental Intelligence

Zacks Small-Cap Research Note for Ainos Inc (AIMD)

Share
bullish•Ainos
•24 Jun 2026 07:39•Issuer-paid

Ainos, Inc.: AI Nose Starts Reading the Breath Itself in New Emergency-Medicine Study at National Ta

VASRO has published an update report on Ainos, Inc. following the company’s announcement of a one-year research program with National Taiwan...

Logo
109 Views
Share
x